These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12023794)

  • 1. Future directions in the development of pemetrexed.
    Calvert H; Bunn PA
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):54-61. PubMed ID: 12023794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pemetrexed in the treatment of colorectal cancer.
    Hochster H
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):54-6. PubMed ID: 12571812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trials of pemetrexed.
    Fossella FV; Gatzemeier U
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):8-16. PubMed ID: 12023787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
    Bunn PA
    Semin Oncol; 2002 Jun; 29(3 Suppl 9):17-22. PubMed ID: 12094334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma.
    Manegold C
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):32-6. PubMed ID: 12917819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of pemetrexed in the treatment of gastrointestinal malignancy.
    Hochster HS
    Clin Colorectal Cancer; 2004 Sep; 4(3):190-5. PubMed ID: 15377402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemetrexed (Alimta): a novel multitargeted antifolate agent.
    Adjei AA
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):145-56. PubMed ID: 12722874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors.
    Hanauske AR; Chen V; Paoletti P; Niyikiza C
    Oncologist; 2001; 6(4):363-73. PubMed ID: 11524555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemetrexed in pancreatic cancer.
    Kindler HL
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):49-53. PubMed ID: 12571811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemetrexed in bladder, head and neck, and cervical cancers.
    Paz-Ares L; Ciruelos E; García-Carbonero R; Castellano D; Lopez-Martín A; Cortés-Funes H
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):69-75. PubMed ID: 12571815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemetrexed: a new cytotoxic agent in the development for first-line non-small-cell lung cancer.
    Scagliotti GV
    Lung Cancer; 2005 Oct; 50 Suppl 1():S18-9. PubMed ID: 16291426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemetrexed in the treatment of selected solid tumors.
    Adjei AA
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):50-3. PubMed ID: 12023793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemetrexed disodium, a novel antifolate with multiple targets.
    Curtin NJ; Hughes AN
    Lancet Oncol; 2001 May; 2(5):298-306. PubMed ID: 11905785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumors.
    Adjei AA
    Ann Oncol; 2000 Oct; 11(10):1335-41. PubMed ID: 11106124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent.
    Solomon B; Bunn PA
    Future Oncol; 2005 Dec; 1(6):733-46. PubMed ID: 16556051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemetrexed, an novel multitargeted antifolate: current development and future directions. Proceedings of a meeting. August 17-19, 2000. Colorado Springs, Colorado, USA.
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):1-61; quiz 62-9. PubMed ID: 12023785
    [No Abstract]   [Full Text] [Related]  

  • 17. Pemetrexed: an active new agent for breast cancer.
    O'Shaughnessy JA
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):57-62. PubMed ID: 12571813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514).
    Jones RJ; Twelves CJ
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):13-22. PubMed ID: 12113062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemetrexed in gastric cancer: clinical experience and future perspectives.
    Celio L; Buzzoni R; Longarini R; Marchianò A; Bajetta E
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):63-8. PubMed ID: 12571814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemetrexed: a promising new treatment for breast cancer.
    O'Shaughnessy JA; Gennari A; Conte P
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):36-41. PubMed ID: 12023791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.